GBT
Headquartered in San Francisco, California and founded in 2011, GBT is a clinical-stage bio pharmaceutical company that discovers, develops and commercializing therapeutics in order to treat blood-based disorders.
Last updated on
About GBT
Estimated Revenue
$100M-$250MEmployees
251-1KFunding / Mkt. Cap
$533MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
BiotechnologyLocation
City
South San FranciscoState
CaliforniaCountry
United StatesTech Stack (67)
